ITMI20021455A0 - Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico - Google Patents

Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico

Info

Publication number
ITMI20021455A0
ITMI20021455A0 IT2002MI001455A ITMI20021455A ITMI20021455A0 IT MI20021455 A0 ITMI20021455 A0 IT MI20021455A0 IT 2002MI001455 A IT2002MI001455 A IT 2002MI001455A IT MI20021455 A ITMI20021455 A IT MI20021455A IT MI20021455 A0 ITMI20021455 A0 IT MI20021455A0
Authority
IT
Italy
Prior art keywords
lexitropsine
phospholipide
formulations
preparation
therapeutic use
Prior art date
Application number
IT2002MI001455A
Other languages
English (en)
Inventor
Ugo Raffaello Citernesi
Federico Arcamone
Original Assignee
Ugo Raffaello Citernesi
Federico Arcamone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugo Raffaello Citernesi, Federico Arcamone filed Critical Ugo Raffaello Citernesi
Priority to IT2002MI001455A priority Critical patent/ITMI20021455A1/it
Publication of ITMI20021455A0 publication Critical patent/ITMI20021455A0/it
Priority to US10/519,889 priority patent/US20060067997A1/en
Priority to JP2004518585A priority patent/JP2006505506A/ja
Priority to EP03762519A priority patent/EP1536771A1/en
Priority to CA002491257A priority patent/CA2491257A1/en
Priority to PCT/EP2003/006745 priority patent/WO2004004691A1/en
Priority to AU2003250849A priority patent/AU2003250849A1/en
Publication of ITMI20021455A1 publication Critical patent/ITMI20021455A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002MI001455A 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico ITMI20021455A1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT2002MI001455A ITMI20021455A1 (it) 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
US10/519,889 US20060067997A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
JP2004518585A JP2006505506A (ja) 2002-07-02 2003-06-26 レキシトロプシンのリン脂質複合体、その製造及び治療剤への使用
EP03762519A EP1536771A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
CA002491257A CA2491257A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
PCT/EP2003/006745 WO2004004691A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations
AU2003250849A AU2003250849A1 (en) 2002-07-02 2003-06-26 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001455A ITMI20021455A1 (it) 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico

Publications (2)

Publication Number Publication Date
ITMI20021455A0 true ITMI20021455A0 (it) 2002-07-02
ITMI20021455A1 ITMI20021455A1 (it) 2004-01-02

Family

ID=11450127

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI001455A ITMI20021455A1 (it) 2002-07-02 2002-07-02 Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico

Country Status (7)

Country Link
US (1) US20060067997A1 (it)
EP (1) EP1536771A1 (it)
JP (1) JP2006505506A (it)
AU (1) AU2003250849A1 (it)
CA (1) CA2491257A1 (it)
IT (1) ITMI20021455A1 (it)
WO (1) WO2004004691A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031015A1 (it) * 2003-05-20 2004-11-21 Naxospharma S R L Poli-(amminopirrolcarbossammidi) per uso nella profilassi e nel trattamento delle endoparassitosi animali e loro composizioni con ciclodestrine.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517922D0 (en) * 1985-07-16 1985-08-21 Erba Farmitalia Carboxamido derivatives
US6187572B1 (en) * 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
NZ514133A (en) * 1996-10-15 2001-09-28 Liposome Co Inc N-acyl phosphatidylethanolamine-mediated liposomal drug delivery
ES2327313T3 (es) * 1999-11-16 2009-10-28 Oncozyme Pharma Inc. Pentamidina para el tratamiento del cancer.
EP1294713A2 (en) * 2000-06-27 2003-03-26 Genelabs Technologies, Inc. Compounds possessing antibacterial, antifungal or antitumor activity

Also Published As

Publication number Publication date
JP2006505506A (ja) 2006-02-16
AU2003250849A1 (en) 2004-01-23
CA2491257A1 (en) 2004-01-15
WO2004004691A1 (en) 2004-01-15
ITMI20021455A1 (it) 2004-01-02
US20060067997A1 (en) 2006-03-30
EP1536771A1 (en) 2005-06-08

Similar Documents

Publication Publication Date Title
IS7714A (is) Lyfjasamsetningar úr módafíníl
NO20044402L (no) Kombinasjonsbehandling av kemokine-medierte sykdommer
CY2013043I1 (el) Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
CY2018005I1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
HK1164133A1 (en) Nasal pharmaceutical formulations and methods of using the same
NO20044054L (no) Administrering av midler for behandling av betennelse
FIU20060389U0 (fi) Luusairauksien hoito
AU2003287526A8 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
NO20042842L (no) Farmasoytiske formuleringer av platina-derivat
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
NO20044916L (no) Preparater av sulfinylacetamid
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EP1560572A4 (en) TOPICAL PEST FORMULATIONS AND METHODS OF TREATMENT
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IL162937A0 (en) Pravastatin pharmaceutical formulations and methods of their use
EP1531795A4 (en) FORMULATIONS LIMITING THE EXTENSION OF PULMONARY INFECTIONS
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
ZA200603542B (en) Oral formulations of desoxypeganine and uses thereof
NO20041968L (no) Anvendelse av cystationin
EE200300328A (et) IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks
DE60238174D1 (de) Fluoropolymere und Herstellungs- und Verwendungsverfahren
ITMI20021455A0 (it) Formulazioni fosfolipidiche di lexitropsine loro preparazione ed impiego terapeutico
EE200300434A (et) Farmatseutiliselt toimivate ühendite kasutamine